Health economics assessment of statin therapy initiation thresholds for atherosclerosis prevention in China: a cost-effectiveness analysis
Abstract Background Recent updates to the Chinese guidelines for dyslipidemia management have reduced the 10-year risk threshold for starting statins in the primary prevention of atherosclerotic heart disease. This study aims to evaluate the potential negative effects of different statin initiation...
Saved in:
Main Authors: | Tianyu Feng, Xiaolin Zhang, Jiaying Xu, Shang Gao, Xihe Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | International Journal for Equity in Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12939-025-02391-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statins—Their Effect on Lipoprotein(a) Levels
by: Marcin Mateusz Granat
Published: (2025-01-01) -
Correspondence on 'Is ChatGPT an Accurate and Reliable Source of Information for Patients with Vaccine and Statin Hesitancy?'
by: Hinpetch DAUNGSUPAWONG, et al.
Published: (2024-06-01) -
An Overview of the Impact of Statin Therapy on Cardiac Incident Risk
by: Urszula Świrk, et al.
Published: (2025-02-01) -
GWAS of CRP response to statins further supports the role of APOE in statin response: A GIST consortium study
by: Emma F. Magavern, et al.
Published: (2025-02-01) -
Association between statin administration and outcome in patients with sepsis: A retrospective study
by: Zhou Jianzhu, et al.
Published: (2025-02-01)